Aims Hypoxic ischaemic encephalopathy (HIE) remains a significant cause of long term
neurodisability despite therapeutic hypothermia (TH). Infants with mild HIE, representing …

Prior to 2005, the management of hypoxic-ischemic encephalopathy (HIE) among term
newborns was limited to intensive supportive care without a specific brainoriented therapy …

Objective This study was aimed to describe utilization of therapeutic hypothermia (TH) in
neonates presenting with mild hypoxic-ischemic encephalopathy (HIE) and associated …

Introduction: We aimed to determine global professional opinion and practice for the use of
therapeutic hypothermia (TH) for treating infants with mild hypoxic-ischaemic …

Early induced therapeutic hypothermia represents the cornerstone treatment in neonates
with probable hypoxic-ischemic encephalopathy. The selection of patients for treatment …

Background We previously reported early results of a randomized trial of whole-body
hypothermia for neonatal hypoxic–ischemic encephalopathy showing a significant reduction …

Objectives To investigate the types of therapeutic hypothermia (TH) used and risk factors
associated with mortality in late-preterm and term neonates (LPTN, gestation of≥ 35 weeks) …

Therapeutic hypothermia (TH) is a recommended regimen for newborn infants who are at or
near term with evolving moderate-to-severe hypoxic ischemic encephalopathy (HIE). The …

Background Despite the introduction of therapeutic hypothermia, infants with moderate-to-
severe hypoxic-ischemic encephalopathy remain at risk of mortality and morbidity. A …

In the past decade a large number of studies of cooling for the treatment of hypoxic-
ischaemic encephalopathy have been reported from middleincome countries (MIC), yet …